Department of Medical Laboratory, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
Oncol Rep. 2013 Sep;30(3):1414-22. doi: 10.3892/or.2013.2598. Epub 2013 Jul 8.
Astrocyte-elevated gene-1 (AEG-1) is implicated in the oncogenesis and angiogenesis of various types of human cancers. However, the biological roles of AEG-1 in cervical carcinoma remain to be further elucidated. In the present study, we demonstrated that the expression of AEG-1 was markedly upregulated in the cervical carcinoma cell lines HeLa, CaSki and SiHa, as well as in 8 paired primary cervical carcinoma tissue (CCT) specimens at both the transcriptional and translational levels when compared with normal cervical epithelial cells (NCECs). Furthermore, immunohistochemical (IHC) analysis demonstrated that 180 of 200 (90%) archived CCT specimens exhibited positive staining for AEG-1, and statistical analysis revealed that the upregulation of AEG-1 was significantly correlated with the clinical staging of the patients (P=0.034), including T (P=0.019), N (P=0.038) and M classification (P=0.018) as well as tumor differentiation (P=0.043). Furthermore, loss‑ and gain‑of‑function results showed that knockdown of AEG-1 expression by specific shRNA not only inhibited SiHa cell proliferation and invasive ability, but also significantly decreased the expression of the angiogenesis-related genes HIF-1α, Tie2, VEGF and TEM1/CD248. Moreover, an increased vascular formation ability was observed in human umbilical vein endothelial cells (HUVECs) co-cultured with conditioned medium both from SiHa cells and NCECs transfected with ectopic AEG-1. In conclusion, these results suggest that elevated expression of AEG-1 plays an important role in the aggressiveness and angiogenesis of cervical carcinoma and that AEG‑1 represents a novel and valuable predictive factor for the prognostic evaluation of cervical carcinoma patients.
星形细胞上调基因-1(AEG-1)参与多种类型人类癌症的发生和血管生成。然而,AEG-1 在宫颈癌中的生物学作用仍有待进一步阐明。在本研究中,我们发现在转录和翻译水平上,AEG-1 在宫颈癌细胞系 HeLa、CaSki 和 SiHa 以及 8 对原发性宫颈癌组织(CCT)标本中均明显上调,而在正常宫颈上皮细胞(NCEC)中则下调。此外,免疫组织化学(IHC)分析表明,200 个存档的 CCT 标本中有 180 个(90%)显示 AEG-1 阳性染色,统计学分析表明 AEG-1 的上调与患者的临床分期显著相关(P=0.034),包括 T(P=0.019)、N(P=0.038)和 M 分类(P=0.018)以及肿瘤分化(P=0.043)。此外,失活和获得功能的结果表明,特异性 shRNA 下调 AEG-1 表达不仅抑制了 SiHa 细胞的增殖和侵袭能力,还显著降低了血管生成相关基因 HIF-1α、Tie2、VEGF 和 TEM1/CD248 的表达。此外,在共培养条件培养基的人脐静脉内皮细胞(HUVECs)中观察到 SiHa 细胞和转染外源性 AEG-1 的 NCEC 中血管形成能力增加。总之,这些结果表明,AEG-1 的高表达在宫颈癌的侵袭性和血管生成中起重要作用,AEG-1 是宫颈癌患者预后评估的一个新的有价值的预测因子。